A milestone for the Tesonet ecosystem: Oxylabs has secured a $130 million strategic investment from Warburg Pincus, reaching a $3.6 billion valuation. More than a decade after being founded within the Tesonet ecosystem, the company becomes its second bootstrapped unicorn and Lithuania’s sixth unicorn overall.
The investment marks Oxylabs’ first outside funding since its founding in 2015 and makes it the second bootstrapped unicorn to emerge from the Tesonet ecosystem, following Nord Security. It also marks another important milestone for Lithuania’s technology ecosystem, with Oxylabs becoming the country’s sixth unicorn.
“Four years after our first raise, a story very much alike. Unicorn No. 2 and counting. Love you, Oxylabs.”
Tomas Okmanas, co-founder at Tesonet
“Such a proud moment for us, but it’s really a win for the whole country. It shows the incredible strength of the community we have here in Lithuania and what it can grow. Just incredibly happy for the Oxylabs team today.”
Eimantas Sabaliauskas, co-founder at Tesonet
Founded within the Tesonet ecosystem in 2015, Oxylabs has grown into a leading global data infrastructure platform purpose-built for the AI era.
As a provider of foundational infrastructure for AI, web intelligence, and enterprise applications, the company will leverage this investment to further extend its competitive advantage and accelerate the development of next-generation products and capabilities.
“The next generation of AI won’t be powered by static indexes that only capture yesterday’s internet. As AI agents begin to navigate the web far more than humans ever have, the future belongs to the live infrastructure that grounds these systems in real-time, interruption free knowledge. This is exactly what Oxylabs has spent the last decade building as a responsible, compliant and ethical operator — infrastructure that already serves many uses, and that this new era depends on,” said Vytautas Savickas, CEO of Oxylabs. “With Warburg Pincus, we will build on our lead in agentic web search infrastructure and product development, and continue executing our long-term strategy.”

“We have proven our ability to execute as the leader in data infrastructure platforms with our portfolio of leading Fortune 500 and AI companies. As we continue to scale our platform, we will focus on expanding and strengthening our global network, further advancing our technology, and delivering even greater value to our customers around the world,” added Jurgis Rudgalvis, Chief Financial Officer of Oxylabs.
Oxylabs is a leading global data infrastructure platform purpose-built for the AI era, providing foundational components of the search and web intelligence ecosystem and the next generation of AI models, agents, and enterprise systems. With over 350,000 customers and $350 million in ARR, Oxylabs has established itself as a critical enabler of large-scale data acquisition across the cybersecurity, e-commerce, and financial industries. From its origins as a premium proxy service, the company is evolving into a full-stack web data infrastructure platform that empowers AI systems to reliably access, interpret, and act on the open web at scale while delivering trusted, structured data to leading Fortune 500 companies.
“Oxylabs has established itself as a leader in data infrastructure through its sophisticated, robust, and compliant technology and expansive network,” said Allison Ross, Principal at Warburg Pincus. “We are excited to support the Oxylabs team as they continue to expand their offering to help their blue-chip customers access and unlock data-driven insights.”
Warburg Pincus Capital Solutions Founders Fund closed in September 2024 with over $4 billion in commitments. Capital Solutions has a flexible mandate that allows it to partner with founders and existing shareholders to provide solutions for balance sheet optimization, shareholder liquidity, M&A, or growth. The group leverages Warburg Pincus’ global platform and firmwide resources across geographies to source and execute on hybrid capital transactions.
Goldman Sachs Bank Europe SE served as sole placement agent for the transaction, with Deloitte Lithuania serving as financial and tax advisor to Oxylabs, and Tegos and Norton Rose Fulbright US and Netherlands serving as legal counsel to Oxylabs.
Lazard acted as financial advisor to Warburg Pincus, while Latham & Watkins LLP, Freshfields, and Sorainen served as its legal counsel.
